| Enhancer ID: | E_01_0203 |
| Species: | human |
| Position : | chr16:28929347-28931347 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Septicemia |
| Pubmed ID: | 31644352 |
| Enhancer experiment: | PCR, flow cytometry, immunofluorescence staining |
| Enhancer experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
| Target gene : | CD19(B4,CVID3) |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
| TF name : | -- |
| TF experiment: | PCR,Flow cytometry,?????? |
| TF experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
| Enhancer function : | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|